Head of Development & CMO, AbbVie
Neil Gallagher, M.D., Ph.D., Vice President of Development and Chief Medical Officer at Abbvie
An Irish native, Dr. Gallagher is a gynecological oncologist with more than 15 years of experience developing oncology drugs including cytotoxics, small molecule kinase inhibitors and biologics across all phases of development at several companies including: AstraZeneca, Astex Therapeutics, Novartis and Amgen. Throughout his career, he has successfully obtained numerous global approvals for both hematological malignancies and solid tumors.
In 2017, Dr. Gallagher joined AbbVie to lead the then new, restructured Oncology Development team and oversaw the Hematology Oncology and Solid Tumor Therapeutic Areas. Two years later he accepted a newly created position as Vice President, Oncology and Development Operations. He was named the Chief Medical Officer and Vice President of Development in January 2020.